Bvf Inc Allakos Inc. Put Options Transaction History
Bvf Inc
- $2.67 Billion
- Q4 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding ALLK
# of Institutions
79Shares Held
68.8MCall Options Held
20.9KPut Options Held
0-
Nea Management Company, LLC Timonium, MD6.15MShares$1.78 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.7MShares$1.65 Million0.3% of portfolio
-
Lynx1 Capital Management LP San Juan, PR3.63MShares$1.05 Million1.7% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$1.04 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$994,1600.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $24.6M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...